Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPITA: Prevnar 13 Efficacy in Older Adults
NCT00744263Phase 4Completed
- Sponsor
- Pfizer
- Start
- Sep 2008
- Primary completion
- Oct 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 13 in Pneumococcal pneumonia (PP), invasive pneumococcal disease (IPD), sponsored by Pfizer. Started Sep 2008; status: completed.
02
Drugs
Prevnar 13
03
Conditions
Pneumococcal pneumonia (PP)invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on NCT00744263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744263.